MKMarianna Kong

Marianna Kong

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Marianna Kong has a total of 18 co-authors. Here are the top co-authors by number of shared publications:

  • Abby Cabrera

    University of California San Francisco Department of Family and Community Medicine San Francisco, CA

    1 shared publication
  • Akash Shanmugam

    University of California San Francisco School of Medicine, San Francisco, California, USA

    1 shared publication
  • Alicia Fernandez

    Department of Medicine, University of California, San Francisco

    1 shared publication
  • Ana Milisavljevic

    Division of Hospital Medicine, University of California San Francisco, San Francisco, California, USA

    1 shared publication
  • Andersen Yang

    Division of General Internal Medicine at Zuckerberg San Francisco General Hospital, Department of Medicine, University of California, San Francisco, 1001 Potrero Avenue, Main Building 5, 1st floor, 1M, San Francisco, CA, 94110, United States, 1 628-206-8000

    1 shared publication
  • Danielle Hessler

    Department of Family Medicine, University of California, San Francisco, CA, USA

    1 shared publication

Latest Publications

  • Open Access

    Pulmonary Specialist Health Coach Consultation model: A randomized controlled trial

    by Rachel Willard-Grace, Abby Cabrera, Stephanie Tsao, Michael B Potter, Danielle Hessler, Marianna Kong, David H Thom, Joan F Hilton, George Su

    Rationale: Socioeconomically disadvantaged patients with asthma and/or chronic obstructive pulmonary disease (COPD) face barriers to evidence-based care that are difficult to overcome in health care settings with limited resources. Objectives: Evaluate the efficacy of a pulmonary-specialist-health coach consultation model (intervention) for patients with asthma and/or COPD, relative to usual care (control). Methods: Randomized-controlled trial of 16 weeks of intervention versus control for adult English- or Spanish-speaking, low-income patients. Intervention: a lay health coach gathered information from the patient and medical record for remote review by a pulmonary specialist, who provided general recommendations to the primary care clinician. The coach supported implementation of recommendations. Measurements: Primary outcomes were receipt of guideline-based care and medications. Secondary outcomes were receipt of chronic lung disease education, breathing-related quality of life and symptoms, patient-rated quality of care, and adherence to inhaler therapy. Longitudinal models for count data were used to estimate Intervention: Control relative rates. Parallel models for continuous data estimated relative means. Main results: 165 intervention participants received 1.61-fold more guideline-based care than 163 control participants (relative ratio; CI: 1.37-1.90). They were not more likely to receive guideline-based medications in planned analysis using a pooled baseline rate, although post-hoc analysis using arm-specific baseline rates found significant improvement. Intervention patients received more chronic lung disease education and reported greater improvements in breathing-related quality of life, symptoms, and patient-reported quality of care. Conclusions: This intervention offers a scalable approach to improve uptake of clinical guidelines in resource-limited primary care practices managing most asthma and COPD care.


  • Top Cited Papers
    Open Access

    Evaluation of the accuracy and safety of machine translation of patient-specific discharge instructions: a comparative analysis

    by Marianna Kong, Alicia Fernandez, Jaskaran Bains, Ana Milisavljevic, Katherine C Brooks, Akash Shanmugam, Leslie Avilez, Junhong Li, Vladyslav Honcharov, Andersen Yang, et al.

    Introduction Machine translation of patient-specific information could mitigate language barriers if sufficiently accurate and non-harmful and may be particularly useful in healthcare encounters when professional translators are not readily available. We evaluated the translation accuracy and potential for harm of ChatGPT-4 and Google Translate in translating from English to Spanish, Chinese and Russian. Methods We used ChatGPT-4 and Google Translate to translate 50 sets (316 sentences) of deidentified, patient-specific, clinician free-text emergency department instructions into Spanish, Chinese and Russian. These were then back-translated into English by professional translators and double-coded by physicians for accuracy and potential for clinical harm. Results At the sentence level, we found that both tools were ≥90% accurate in translating English to Spanish (accuracy: GPT 97%, Google Translate 96%) and English to Chinese (accuracy: GPT 95%; Google Translate 90%); neither tool performed as well in translating English to Russian (accuracy: GPT 89%; Google Translate 80%). At the instruction set level, 16%, 24% and 56% of Spanish, Chinese and Russian GPT-translated instruction sets contained at least one inaccuracy. For Google Translate, 24%, 56% and 66% of Spanish, Chinese and Russian translations contained at least one inaccuracy. The potential for harm due to inaccurate translations was ≤1% for both tools in all languages at the sentence level and ≤6% at the instruction set level. GPT was significantly more accurate than Google Translate in Chinese and Russian at the sentence level; the potential for harm was similar. Conclusion These results support the potential of machine translation tools to mitigate gaps in translation services for low-stakes written communication from English to Spanish, while also strengthening the case for caution and for professional oversight in non-low-risk communication. Further research is needed to evaluate machine translation for other languages and more technical content.